Education and Training
Side Effects of Pulmonary Hypertension Medications
The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric population. This information can better improve patient care and be used to characterize the side effects resultant from these medications.
Stanford is currently not accepting patients for this trial.
Eligibility
Inclusion Criteria:
- pulmonary hypertension
- currently taking at least one of the following PH medications (Bosentan, Epoprostenol,
Letairis, Sildenafil, Tadalafil, Treprostinil, Ventaris)
Exclusion Criteria:
- >18 years
Ages Eligible for Study
N/A - 18 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Jeffrey Feinstein, MD, MPH
650-723-7913
Not Recruiting